You are here: Home > Former > 2013

2013

The International Association for Cannabinoid Medicines hold its 2013 Meeting on September 27-28, 2013 at the Leonardo Royal Hotel am Stadtwald, Cologen.

Please klick here for the Abstract Book of the Cologne 2013 Meeting with program, lecture and poster abstracts.

The IACM honoured four people for their major contributions to cannabinoid research and/or to the re-introduction of cannabis into modern medicine with the IACM Award. In 2013 the Ester Fride Award for Basic Research went to Vincenzo Di Marzo, the IACM Award for Clinical Research to Philip Robson, the IACM Award for Young Researchers to Tibor Harkany and the IACM Special Award went to Roger Pertwee.

Silver Sponsors

Bedrocan
Bionorica Ethics

Bronze Sponsors

Almirall
Fundacion Canna
THC Pharm
Terra Energetika
Medical Cannabis Bike Tour
Phytoplant Research



































Free Online Events 2020

You can find all information here.

The IACM is holding a free webinar series and a free anniversary online meeting from October to December 2020

All webinars will be held in English with subtitles in German, French, Spanish, and Portuguese. All webinars will be available online until March 2021

The anniversary online meeting to celebrate the IACM's 20th anniversary and to honour the 90th birthday of Raphael Mechoulam will be a live session only on the 5th November 2020.

The speakers in the webinar series are Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli, and Ethan Russo.

You can find all information here.
 

IACM Conference 2021

The 12th IACM Conference on Cannabinoids in Medicine will be held in Basel, Switzerland, from 14 to 16 October 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.